You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Permethrin - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for permethrin and what is the scope of freedom to operate?

Permethrin is the generic ingredient in three branded drugs marketed by Aurobindo Pharma Usa, Actavis Labs, Dr Reddys Labs Eu, Encube Ethicals, Padagis Israel, Glaxosmithkline, Medtech Products, Actavis Mid Atlantic, and Perrigo New York, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for permethrin. Twenty-one suppliers are listed for this compound.

Drug Prices for permethrin

See drug prices for permethrin

Drug Sales Revenue Trends for permethrin

See drug sales revenues for permethrin

Recent Clinical Trials for permethrin

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Universitas PadjadjaranPhase 4
Alliance PharmaceuticalsN/A
Concentrics ResearchPhase 4

See all permethrin clinical trials

Pharmacology for permethrin
Drug ClassPyrethroid
Medical Subject Heading (MeSH) Categories for permethrin

US Patents and Regulatory Information for permethrin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo New York PERMETHRIN permethrin LOTION;TOPICAL 076090-001 Dec 20, 2001 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Actavis Mid Atlantic PERMETHRIN permethrin LOTION;TOPICAL 075014-001 Mar 28, 2000 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Actavis Labs PERMETHRIN permethrin CREAM;TOPICAL 074806-001 Jan 23, 1998 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Glaxosmithkline NIX permethrin LOTION;TOPICAL 019435-001 Mar 31, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.